Home » Spectranetics Wins CE Mark for Smaller Stellarex DCB
Spectranetics Wins CE Mark for Smaller Stellarex DCB
Spectranetics has received CE Marking for its Stellarex 0.014 drug-coated angioplasty balloon (DCB).
The device is designed to treat small vessels, below-the-knee disease and critical limb ischemia in patients.
Stellarex is not available in the U.S. — Cynthia Jessup
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May